NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,125 filers reported holding NOVARTIS A G in Q2 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $220,766,984 | -1.9% | 2,167,357 | -2.8% | 0.04% | 0.0% |
| Q2 2023 | $225,038,987 | -3.6% | 2,230,096 | -12.1% | 0.04% | -6.5% |
| Q1 2023 | $233,362,600 | +1.5% | 2,536,550 | +0.1% | 0.05% | -4.2% |
| Q4 2022 | $229,860,893 | +15.1% | 2,533,740 | -3.6% | 0.05% | +4.3% |
| Q3 2022 | $199,687,000 | -14.6% | 2,627,123 | -5.1% | 0.05% | -8.0% |
| Q2 2022 | $233,961,000 | -6.2% | 2,767,794 | -2.6% | 0.05% | +13.6% |
| Q1 2022 | $249,472,000 | -8.2% | 2,842,988 | -8.5% | 0.04% | -2.2% |
| Q4 2021 | $271,881,000 | +2.1% | 3,108,273 | -4.5% | 0.04% | -4.3% |
| Q3 2021 | $266,161,000 | -18.2% | 3,254,598 | -8.8% | 0.05% | -17.5% |
| Q2 2021 | $325,439,000 | -0.5% | 3,566,833 | -6.8% | 0.06% | -6.6% |
| Q1 2021 | $327,094,000 | -9.5% | 3,826,553 | -0.1% | 0.06% | -12.9% |
| Q4 2020 | $361,620,000 | +7.1% | 3,829,501 | -1.3% | 0.07% | -5.4% |
| Q3 2020 | $337,568,000 | +2.8% | 3,881,881 | +3.2% | 0.07% | -5.1% |
| Q2 2020 | $328,408,000 | +10.6% | 3,760,103 | +4.4% | 0.08% | -8.2% |
| Q1 2020 | $296,990,000 | -21.6% | 3,602,066 | -10.0% | 0.08% | 0.0% |
| Q4 2019 | $378,861,000 | +10.3% | 4,001,072 | +1.3% | 0.08% | +3.7% |
| Q3 2019 | $343,354,000 | -5.1% | 3,951,141 | -0.3% | 0.08% | -4.7% |
| Q2 2019 | $361,865,000 | -3.8% | 3,963,027 | +1.3% | 0.09% | -7.5% |
| Q1 2019 | $376,053,000 | +8.3% | 3,911,509 | -3.3% | 0.09% | -4.1% |
| Q4 2018 | $347,164,000 | -3.7% | 4,045,738 | -3.3% | 0.10% | +10.2% |
| Q3 2018 | $360,410,000 | +16.6% | 4,183,041 | +2.2% | 0.09% | +12.8% |
| Q2 2018 | $309,110,000 | -6.5% | 4,092,017 | +0.1% | 0.08% | -9.3% |
| Q1 2018 | $330,642,000 | -1.5% | 4,089,571 | +2.3% | 0.09% | +1.2% |
| Q4 2017 | $335,804,000 | -1.3% | 3,999,561 | +0.9% | 0.08% | -4.5% |
| Q3 2017 | $340,281,000 | +1.8% | 3,963,664 | -1.1% | 0.09% | -5.3% |
| Q2 2017 | $334,424,000 | +12.7% | 4,006,516 | +0.2% | 0.09% | +9.3% |
| Q1 2017 | $296,844,000 | +2.6% | 3,996,817 | +0.6% | 0.09% | -3.4% |
| Q4 2016 | $289,358,000 | +7.0% | 3,972,512 | +16.0% | 0.09% | +6.0% |
| Q3 2016 | $270,452,000 | -6.7% | 3,425,170 | -2.5% | 0.08% | -10.6% |
| Q2 2016 | $289,927,000 | +10.3% | 3,513,843 | +0.0% | 0.09% | +8.0% |
| Q1 2016 | $262,749,000 | -6.1% | 3,512,378 | +8.0% | 0.09% | -6.5% |
| Q4 2015 | $279,784,000 | -14.3% | 3,251,793 | -8.4% | 0.09% | -14.7% |
| Q3 2015 | $326,411,000 | -10.9% | 3,551,038 | -4.6% | 0.11% | -0.9% |
| Q2 2015 | $366,207,000 | -1.5% | 3,723,896 | -1.2% | 0.11% | -1.8% |
| Q1 2015 | $371,597,000 | +5.1% | 3,768,344 | -1.3% | 0.11% | +4.7% |
| Q4 2014 | $353,600,000 | +13.1% | 3,816,105 | +14.9% | 0.11% | +9.2% |
| Q3 2014 | $312,580,000 | -14.4% | 3,320,724 | -17.7% | 0.10% | -14.0% |
| Q2 2014 | $365,282,000 | +32.8% | 4,034,921 | +24.7% | 0.11% | +31.0% |
| Q1 2014 | $274,992,000 | +26.4% | 3,234,435 | +19.5% | 0.09% | +24.3% |
| Q4 2013 | $217,522,000 | -13.1% | 2,706,178 | -17.0% | 0.07% | -20.5% |
| Q3 2013 | $250,179,000 | +10.3% | 3,261,354 | +1.6% | 0.09% | +7.3% |
| Q2 2013 | $226,896,000 | – | 3,208,832 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |